This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Ramasamy Vijaya Anand: Innovator in Osteoporosis Treatment
Introduction
Ramasamy Vijaya Anand is a notable inventor based in Kanpur, India. He has made significant contributions to the field of medical science, particularly in the treatment of osteoporosis. His innovative approach has led to the development of a unique method and composition that addresses this prevalent condition.
Latest Patents
Ramasamy Vijaya Anand holds 1 patent for his invention titled "Method and composition for treating osteoporosis." This invention introduces a novel class of acidic amino acid/dicarboxylic acid derivatives, specifically sulfonic acid/sulfate derivatives of naturally occurring amino acids and their amides. These compounds serve as inhibitors of osteoclastogenesis, which is crucial in the management of osteoporosis. The invention outlines methods for utilizing these derivatives, represented by the general formula ZOC—(CRR)—COOH, where specific parameters define their structure and function.
Career Highlights
Ramasamy Vijaya Anand is affiliated with the Council of Scientific & Industrial Research, where he has been instrumental in advancing research in his field. His work has not only contributed to scientific knowledge but also holds potential for practical applications in healthcare.
Collaborations
Throughout his career, Ramasamy has collaborated with esteemed colleagues, including Kanury Venkata Subba Rao and Mohan Ramachandran Wani. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Ramasamy Vijaya Anand's contributions to the treatment of osteoporosis through his innovative patent demonstrate his commitment to advancing medical science. His work exemplifies the impact of research and innovation in addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
